MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dyskinesias"

  • 2018 International Congress

    The scaling properties of chorea and levodopa-induced dyskinesia are similar to voluntary movements

    J. Daneault, C. Duval, J. Miranda (Newark, NJ, USA)

    Objective: Explore whether levodopa-induced dyskinesia (LID) and chorea share voluntary movement characteristics to better understand the mechanisms underlying these involuntary movements. Background: We have recently…
  • 2018 International Congress

    Prevalence and risk factor of peak-dose dyskinesia in Thai patients with Parkinson’s disease

    S. Klanbut, C. Luangsinsiri, N. Piyaparneekul, C. Khongbut, K. Methawasin (Nakhon Nayok, Thailand)

    Objective: To determine the prevalence and risk factors associated with peak-dose dyskinesia in Thai patients with Parkinson’s disease. Background: Dyskinesias are involuntary movement that interfere…
  • 2018 International Congress

    Crack Dancing: An Uncommon Drug-Induced Chorea

    G. Gibb, D. Nacopoulos (Erie, PA, USA)

    Objective: To report a unique case of cocaine induced choreiform dyskinetic movements with literature review of this condition. Background: Various abnormal movements have been known…
  • 2018 International Congress

    A phase Ib trial studying the safety and tolerability of IRL790 in patients with Parkinson’s disease and levodopa-induced dyskinesia

    P. Svenningsson, A. Johansson, D. Nyholm, P. Tsitsi, C. Sonesson, J. Tedroff (Stockholm, Sweden)

    Objective: The primary objective was to investigate the safety and tolerability of IRL790 in PD patients with LID in a randomized controlled trial. Background: IRL790…
  • 2018 International Congress

    Clinical experiences in Whole systems Ayurveda Management of Parkinson’s Disease

    P. Shankar, P. R, P. Devkumar, A. Godbole, U. Muthane (Bangalore, India)

    Objective: PD Assessment of Ayurveda management using UPDRS -Motor, Hoehn & Yahr staging, Activity of Daily Living % (ADL). Background: Ayurveda holistic management comprises an…
  • 2018 International Congress

    Item Response Theory Analysis of the Unified Dyskinesia Rating Scale Items

    C. Goetz, S. Luo, G. Stebbins (Chicago, IL, USA)

    Objective: To investigate the measurement characteristics of the Unified Dyskinesia Rating Scale (UDysRS) using item response theory (IRT) approaches. Background: The UDysRS has become the…
  • 2018 International Congress

    What is the relationship between dyskinesia and performance of activities of daily living in patients with Parkinson’s disease?

    E. Goubault, S. Bogard, K. Lebel, C. Duval (Montreal, QC, Canada)

    Objective: The aim of this study was to determine which of drug-induced dyskinesia (DID) or other symptoms of Parkinson's disease (PD) had the most impact…
  • 2018 International Congress

    Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry

    D. Johansson, A. Ericsson, A. Johansson, A. Medvedev, D. Nyholm, F. Ohlsson, M. Senek, J. Spira, I. Thomas, J. Westin, F. Bergquist (Gothenburg, Sweden)

    Objective: This four-week open-label observational study describes the effect of introducing a microtablet dose dispenser and adjusting doses based on objective free-living motor symptom monitoring…
  • 2018 International Congress

    Chronological view of peak and diphasic dyskinesia, wearing off and freezing in Parkinson’s disease: 1212 Korean population

    Y.E. Kim, B. Jeon. (Anyang, Republic of Korea)

    Objective: To evaluate the gross chronological trend of 4 motor complications - peak dose dyskinesia, diphasic dyskinesia, wearing off and freezing. Background: Dyskinesia, wearing off…
  • 2018 International Congress

    Differences in the Unified Dyskinesia Rating Scale based on age, Parkinson´s Disease and Dyskinesias duration

    E. Cubo, S. Luo, S. Calvo, P. Martinez-Martín (Burgos, Spain)

    Objective: To analyze the Unified Dyskinesia Rating Scale (UDysRS) scores on Historical, Objective parts and their differences based on age, Parkinson´s disease (PD) and dyskinesias…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 40
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley